Skip to main content
. 2020 Jun 11;15(7):1007–1014. doi: 10.2215/CJN.13861119

Figure 1.

Figure 1.

Relative supersaturation ratios at baseline and at 1-year follow-up. Relative supersaturation ratios for calcium oxalate (A), brushite (B), and uric acid (C) in participants with or without Tolvaptan treatment at follow-up. All participants were Tolvaptan-naïve at baseline. Baseline: left side of panel, 1-year follow-up: right side of panel.